1149752-51-1 Usage
Description
(R)-N-((S)-1-(5-fluoropyridin-2-yl)ethyl)-2-Methylpropane-2-sulfinaMide is a chemical compound characterized by a chiral center and a sulfonamide group. It is a white to off-white solid that holds significant potential in pharmaceutical research and development, particularly in the fields of neuroscience and oncology. (R)-N-((S)-1-(5-fluoropyridin-2-yl)ethyl)-2-Methylpropane-2-sulfinaMide has demonstrated promising pharmacological properties in preclinical studies, positioning it as a noteworthy subject in drug discovery. Its unique structure also renders it a valuable building block for the synthesis of new chemical entities with potential therapeutic applications.
Uses
Used in Pharmaceutical Research and Development:
(R)-N-((S)-1-(5-fluoropyridin-2-yl)ethyl)-2-Methylpropane-2-sulfinaMide is used as a potential candidate for the treatment of various medical conditions, particularly in the fields of neuroscience and oncology, due to its demonstrated pharmacological properties in preclinical studies.
Used in Drug Synthesis:
In the chemical industry, (R)-N-((S)-1-(5-fluoropyridin-2-yl)ethyl)-2-Methylpropane-2-sulfinaMide is used as a valuable building block for the synthesis of new chemical entities with potential therapeutic applications, leveraging its unique structure to create novel compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1149752-51-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,9,7,5 and 2 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1149752-51:
(9*1)+(8*1)+(7*4)+(6*9)+(5*7)+(4*5)+(3*2)+(2*5)+(1*1)=171
171 % 10 = 1
So 1149752-51-1 is a valid CAS Registry Number.
1149752-51-1Relevant articles and documents
P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN
-
Paragraph 120; 0124, (2018/02/04)
The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor s
P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN
-
Page/Page column 66, (2010/11/18)
The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.
Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors
Ioannidis, Stephanos,Lamb, Michelle L.,Davies, Audrey M.,Almeida, Lynsie,Su, Mei,Bebernitz, Geraldine,Ye, Minwei,Bell, Kirsten,Alimzhanov, Marat,Zinda, Michael
scheme or table, p. 6524 - 6528 (2010/05/18)
The design, synthesis and biological evaluation of a series of pyrazol-3-ylamino pyrazines as potent and selective JAK2 kinase inhibitors is reported, along with the pharmacokinetic and pharmacodynamic properties of lead compounds.
